IVERIC bio, Inc. Operating Cash Flow
IVERIC bio, Inc. reported Operating Cash Flow of -$50.59 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2023-05-10
- IVERIC bio, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was -$50.59M.
- IVERIC bio, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-12-31 was -$49.23M.
- IVERIC bio, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was -$41.12M.
- IVERIC bio, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-06-30 was -$35.91M.
- IVERIC bio, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$163.77M.
- IVERIC bio, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$98.56M.
- IVERIC bio, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$66.10M.
- IVERIC bio, Inc. net cash provided by (used in) operating activities for fiscal 2019 was -$48.49M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2023-03-31 | -$50.59M 10-Q · filed 2023-05-10 | -$99.83M derived: sum of 2 quarters · filed 2023-05-10 | -$140.94M derived: sum of 3 quarters · filed 2023-05-10 | -$176.85M derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | -$49.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$90.35M derived: sum of 2 quarters · filed 2023-03-01 | -$126.26M derived: sum of 3 quarters · filed 2023-03-01 | -$163.77M 10-K · filed 2023-03-01 |
| 2022-09-30 | -$41.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$77.03M derived: sum of 2 quarters · filed 2022-11-04 | -$114.54M 10-Q · filed 2022-11-04 | -$136.97M derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-06-30 | -$35.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-26 | -$73.42M 10-Q · filed 2022-07-26 | -$95.86M derived: sum of 3 quarters · filed 2023-05-10 | -$122.07M derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-03-31 | -$37.51M 10-Q · filed 2023-05-10 | -$59.95M derived: sum of 2 quarters · filed 2023-05-10 | -$86.16M derived: sum of 3 quarters · filed 2023-05-10 | -$106.61M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$22.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$48.65M derived: sum of 2 quarters · filed 2023-03-01 | -$69.10M derived: sum of 3 quarters · filed 2023-03-01 | -$98.56M 10-K · filed 2023-03-01 |
| 2021-09-30 | -$26.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$46.67M derived: sum of 2 quarters · filed 2022-11-04 | -$76.13M 10-Q · filed 2022-11-04 | -$97.19M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$20.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-26 | -$49.91M 10-Q · filed 2022-07-26 | -$70.98M derived: sum of 3 quarters · filed 2023-03-01 | -$85.73M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$29.46M 10-Q · filed 2022-05-04 | -$50.53M derived: sum of 2 quarters · filed 2023-03-01 | -$65.28M derived: sum of 3 quarters · filed 2023-03-01 | -$78.03M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$21.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$35.83M derived: sum of 2 quarters · filed 2023-03-01 | -$48.57M derived: sum of 3 quarters · filed 2023-03-01 | -$66.10M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$14.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$27.50M derived: sum of 2 quarters · filed 2021-11-09 | -$45.03M 10-Q · filed 2021-11-09 | -$56.94M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$12.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$30.27M 10-Q · filed 2021-08-04 | -$42.18M derived: sum of 3 quarters · filed 2022-02-24 | -$54.41M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$17.53M 10-Q · filed 2021-05-05 | -$29.43M derived: sum of 2 quarters · filed 2022-02-24 | -$41.66M derived: sum of 3 quarters · filed 2022-02-24 | -$51.41M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$11.91M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$24.14M derived: sum of 2 quarters · filed 2022-02-24 | -$33.89M derived: sum of 3 quarters · filed 2022-02-24 | -$48.49M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$12.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | -$21.98M derived: sum of 2 quarters · filed 2020-11-03 | -$36.58M 10-Q · filed 2020-11-03 | -$46.66M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | -$9.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$24.35M 10-Q · filed 2020-08-06 | -$34.44M derived: sum of 3 quarters · filed 2021-03-04 | -$45.26M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | -$14.60M 10-Q · filed 2020-05-07 | -$24.68M derived: sum of 2 quarters · filed 2021-03-04 | -$35.51M derived: sum of 3 quarters · filed 2021-03-04 | -$44.43M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | -$10.08M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$20.90M derived: sum of 2 quarters · filed 2021-03-04 | -$29.82M derived: sum of 3 quarters · filed 2021-03-04 | -$41.91M 10-K · filed 2021-03-04 |
| 2018-09-30 | -$10.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$19.74M derived: sum of 2 quarters · filed 2019-11-12 | -$31.83M 10-Q · filed 2019-11-12 | -$45.07M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$8.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$21.01M 10-Q · filed 2019-08-01 | -$34.25M derived: sum of 3 quarters · filed 2020-02-27 | -$50.33M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$12.09M 10-Q · filed 2019-05-08 | -$25.33M derived: sum of 2 quarters · filed 2020-02-27 | -$41.41M derived: sum of 3 quarters · filed 2020-02-27 | -$72.40M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | -$13.24M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$29.32M derived: sum of 2 quarters · filed 2020-02-27 | -$60.31M derived: sum of 3 quarters · filed 2020-02-27 | -$121.82M 10-K · filed 2020-02-27 |
| 2017-09-30 | -$16.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | -$47.06M derived: sum of 2 quarters · filed 2018-11-02 | -$108.58M 10-Q · filed 2018-11-02 | -$141.39M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | -$30.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$92.50M 10-Q · filed 2018-08-01 | -$125.31M derived: sum of 3 quarters · filed 2019-02-28 | -$131.14M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | -$61.51M 10-Q · filed 2018-05-09 | -$94.32M derived: sum of 2 quarters · filed 2019-02-28 | -$100.14M derived: sum of 3 quarters · filed 2019-02-28 | |
| 2016-12-31 | -$32.81M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$38.63M derived: sum of 2 quarters · filed 2019-02-28 | -$108.60M 10-K · filed 2019-02-28 | |
| 2016-09-30 | -$5.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$75.78M 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | -$69.96M 10-Q · filed 2017-08-02 | |||
| 2015-12-31 | -$78.53M 10-K · filed 2018-03-05 |